Annual Total Long Term Liabilities
$31.57 M
+$12.03 M+61.60%
December 31, 2023
Summary
- As of February 24, 2025, TARS annual total long term liabilities is $31.57 million, with the most recent change of +$12.03 million (+61.60%) on December 31, 2023.
- During the last 3 years, TARS annual total long term liabilities has risen by +$30.96 million (+5117.69%).
- TARS annual total long term liabilities is now -50.29% below its all-time high of $63.50 million, reached on December 31, 2019.
Performance
TARS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$72.95 M
-$79.00 K-0.11%
September 30, 2024
Summary
- As of February 24, 2025, TARS quarterly total long term liabilities is $72.95 million, with the most recent change of -$79.00 thousand (-0.11%) on September 30, 2024.
- Over the past year, TARS quarterly long term liabilities has stayed the same.
- TARS quarterly long term liabilities is now -29.77% below its all-time high of $103.87 million, reached on September 30, 2020.
Performance
TARS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TARS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.6% | 0.0% |
| 3 y3 years | +5117.7% | 0.0% |
| 5 y5 years | +785.7% | 0.0% |
TARS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4416.0% | -0.1% | >+9999.0% |
| 5 y | 5-year | -50.3% | +5117.7% | -29.8% | >+9999.0% |
| alltime | all time | -50.3% | +5117.7% | -29.8% | >+9999.0% |
Tarsus Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $72.95 M(-0.1%) |
| Jun 2024 | - | $73.03 M(+131.5%) |
| Mar 2024 | - | $31.54 M(-0.1%) |
| Dec 2023 | $31.57 M(+61.6%) | $31.57 M(+0.5%) |
| Sep 2023 | - | $31.42 M(+18.9%) |
| Jun 2023 | - | $26.43 M(+7.6%) |
| Mar 2023 | - | $24.55 M(+25.7%) |
| Dec 2022 | $19.53 M | $19.53 M(-0.2%) |
| Sep 2022 | - | $19.57 M(-0.2%) |
| Jun 2022 | - | $19.61 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.68 M(+2714.9%) |
| Dec 2021 | $699.00 K(+15.5%) | $699.00 K(-22.8%) |
| Sep 2021 | - | $905.00 K(+72.7%) |
| Jun 2021 | - | $524.00 K(-13.2%) |
| Mar 2021 | - | $604.00 K(-0.2%) |
| Dec 2020 | $605.00 K(-99.0%) | $605.00 K(-99.4%) |
| Sep 2020 | - | $103.87 M(>+9900.0%) |
| Jun 2020 | - | $797.00 K(-98.7%) |
| Dec 2019 | $63.50 M(+1681.8%) | $63.50 M |
| Dec 2018 | $3.56 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Tarsus Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of TARS is $31.57 M
What is the all time high annual total long term liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total long term liabilities is $63.50 M
What is Tarsus Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, TARS annual total long term liabilities has changed by +$12.03 M (+61.60%)
What is Tarsus Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of TARS is $72.95 M
What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total long term liabilities is $103.87 M
What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, TARS quarterly total long term liabilities has changed by $0.00 (0.00%)